Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Hepatitis C Medicines

  • First published: 06 June 2019
  • Last modified: 06 June 2019
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Authority ID:
AA20671
Publication date:
06 June 2019
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

This Framework Agreement is for the supply of branded medicines under a capped spend model used in the treatment of Hepatitis C to NHSScotland.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)

Gyle Square (NSS Head Office), 1 South Gyle Crescent

Edinburgh

EH12 9EB

UK

Contact person: Laura Ferguson

Telephone: +44 1312756725

E-mail: lauraferguson1@nhs.net

NUTS: UKM

Internet address(es)

Main address: http://www.nhsscotlandprocurement.scot.nhs.uk/

Address of the buyer profile: https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Hepatitis C Medicines

Reference number: NP49119

II.1.2) Main CPV code

33600000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland.

Pricing was requested under two (2) pricing models as outlined below:

Lot 1: Treatment Cost per Medicine;

Lot 2: Treatment Spend Cap.

II.1.6) Information about lots

This contract is divided into lots: Yes

II.1.7) Total value of the procurement

Value excluding VAT: 32 583 000.00  GBP

II.2) Description

Lot No: 1

II.2.1) Title

Treatment Cost per Medicine

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UKM


Main site or place of performance:

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

II.2.4) Description of the procurement

This Framework Agreement is for the supply of medicines used in the treatment of Hepatitis C to NHSScotland.

II.2.5) Award criteria

Quality criterion: Treatment duration / Weighting: 2.5

Quality criterion: Genotype testing / Weighting: 2.5

Price / Weighting:  95

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 2

II.2.1) Title

Treatment Spend Cap

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UKM


Main site or place of performance:

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

II.2.4) Description of the procurement

This Framework Agreement is for the supply of branded medicines under a capped spend model used in the treatment of Hepatitis C to NHSScotland.

II.2.5) Award criteria

Quality criterion: Treatment duration / Weighting: 2.5

Quality criterion: Genotype testing / Weighting: 2.5

Price / Weighting:  95

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2019/S 053-121476

Section V: Award of contract

Lot No: 1

Title: Treatment Cost per Medicine

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

08/05/2019

V.2.2) Information about tenders

Number of tenders received: 3

The contract has been awarded to a group of economic operators: Yes

V.2.3) Name and address of the contractor

AbbVie Ltd

Abbvie House, Vanwall Business Park

Maidenhead

SL6 4UB

UK

Telephone: +44 7775116875

NUTS: UK

The contractor is an SME: No

V.2.3) Name and address of the contractor

Gilead Sciences Ltd

280 High Holborn

London

WC1V 7EE

UK

Telephone: +44 7747473021

NUTS: UK

The contractor is an SME: No

V.2.3) Name and address of the contractor

MSD

Hertford Road, Hoddesdon

Herts

EN11 9BU

UK

Telephone: +44 1992455245

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 9 775 000.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 2

Title: Treatment Spend Cap

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

08/05/2019

V.2.2) Information about tenders

Number of tenders received: 2

The contract has been awarded to a group of economic operators: Yes

V.2.3) Name and address of the contractor

AbbVie Ltd

Abbvie House, Vanwall Business Park

Maidenhead

SL6 4UB

UK

Telephone: +44 7775116875

NUTS: UK

The contractor is an SME: No

V.2.3) Name and address of the contractor

Gilead Sciences Ltd

280 High Holborn

London

WC1V 7EE

UK

Telephone: +44 7747473021

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 22 808 333.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

The estimated value range referred to in Sections II.I.5 and all Lots covers the twenty two (22) months initial duration and the maximum twelve (12)-month extension period.

(SC Ref:585089)

VI.4) Procedures for review

VI.4.1) Review body

The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)

Gyle Square (NSS Head Office), 1 South Gyle Crescent

Edinburgh

EH12 9EB

UK

Telephone: +44 1698794410

Internet address(es)

URL: http://www.nhsscotlandprocurement.scot.nhs.uk/

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

VI.5) Date of dispatch of this notice

04/06/2019

Coding

Commodity categories

ID Title Parent category
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
lauraferguson1@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.